All posts
Product

Veropital 2026 roadmap: what we'll build, and what we won't

Our year ahead: AI X-ray analysis, dental tourism packages, multi-currency. And specifically the three things we won't do.

Faraz Azarmi··3 min read
Product

Each year we share our roadmap publicly with the people who use Veropital. Here's where we're going in 2026 — the three big projects we've prioritized, and why we're saying no to a few popular requests.

01

Will do: AI X-ray analysis

We're working on an X-ray analysis module that runs in Turkish, hosted on GDPR/KVKK-aligned servers. Caries, periapical lesion, bone-loss detection — a second pair of eyes for the dentist.

It won't make the treatment call. It just flags. Targeting September 2026.

02

Will do: Dental tourism packages

It's no longer news that Türkiye is the world's largest dental exporter. We're building a module that bundles treatment plan, hotel booking, transfer, and payment for international patients into a single package.

Pilot launched at four clinics in March; general availability in June.

03

Will do: Multi-currency

EUR and USD treatment packages, FX tracking, invoicing. The natural counterpart to dental tourism.

May 2026.

04

Won't do

One: a separate product for general medicine. Veropital stays dental.

Two: instant messaging. WhatsApp and SMS are enough; we won't roll our own.

Three: a patient social network. The patient belongs in the clinic, not in our product.